(Boston, MA, April 13, 2016) – The Clinton Health Access Initiative, Inc. (CHAI) and AmeriCares, with the aid of a multi-year product-donation from Bristol-Myers Squibb, have initiated a first-of-its-kind program in Africa and Asia aimed at curing hepatitis C (HCV) among patients co-infected with HCV and human immunodeficiency virus (HIV). Bristol-Myers Squibb has agreed to immediately begin providing enough of the HCV medicine Daklinza (daclatasvir) to treat 10,000 patients.


click here to read the whole story